Last Updated: June 9, 2026

Suppliers and packagers for AUROVELA 1.5/30


✉ Email this page to a colleague

« Back to Dashboard


AUROVELA 1.5/30

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma AUROVELA 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 207581 ANDA Aurobindo Pharma Limited 65862-935-54 5 POUCH in 1 CARTON (65862-935-54) / 1 BLISTER PACK in 1 POUCH / 21 TABLET in 1 BLISTER PACK 2017-06-26
Aurobindo Pharma AUROVELA 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 207581 ANDA Aurobindo Pharma Limited 65862-935-74 3 POUCH in 1 CARTON (65862-935-74) / 1 BLISTER PACK in 1 POUCH / 21 TABLET in 1 BLISTER PACK 2017-06-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for AUROVELA 1.5/30

Last updated: June 9, 2026

Aurovela 1.5/30 (norethindrone acetate 1.5 mg + ethinyl estradiol 30 mcg): What suppliers make the product and what inputs matter for sourcing

Executive summary: AUROVELA 1.5/30 is a combined oral contraceptive (COC) tablet delivering norethindrone acetate (NETA) 1.5 mg + ethinyl estradiol (EE 30 mcg). The product is typically sourced through a CDMO/CDMO-to-drug-product supply chain: API manufacturers for NETA and EE, excipient suppliers for tablet cores, packaging suppliers for blister/bottle, and contract manufacturing for compression/coating/finish plus labeling. Supplier access and quality qualification are usually governed by ANDA/DMF-linked sourcing for APIs and current Good Manufacturing Practice (cGMP) supply agreements for drug product.

Because supplier lists for AUROVELA 1.5/30 are not comprehensively published as a single authoritative public roster, the practical “supplier” answer is operational: the API manufacturers and drug-product/CDMO sites that appear via FDA-facing documentation (DMFs, labeling, inspections, and commercial manufacturing disclosures) and the packaging/fulfillment partners that show up through product-level logistics and casework.

No complete, verifiable supplier roster for AUROVELA 1.5/30 can be produced from the information available here without risking factual errors.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.